Correlation Between Praxis Precision and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Praxis Precision and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Pasithea Therapeutics.
Diversification Opportunities for Praxis Precision and Pasithea Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Praxis and Pasithea is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Praxis Precision i.e., Praxis Precision and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Praxis Precision and Pasithea Therapeutics
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.97 times more return on investment than Pasithea Therapeutics. However, Praxis Precision Medicines is 1.03 times less risky than Pasithea Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.21 per unit of risk. If you would invest 7,154 in Praxis Precision Medicines on August 26, 2024 and sell it today you would earn a total of 296.00 from holding Praxis Precision Medicines or generate 4.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Praxis Precision Med |
| Pasithea Therapeutics |
Praxis Precision and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and Pasithea Therapeutics
The main advantage of trading using opposite Praxis Precision and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Praxis Precision vs. Molecular Partners AG | Praxis Precision vs. Mineralys Therapeutics, Common | Praxis Precision vs. AN2 Therapeutics | Praxis Precision vs. Pharvaris BV |
| Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. HCW Biologics | Pasithea Therapeutics vs. Scpharmaceuticals | Pasithea Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |